Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2022-08-17 00:00:00 ET · period of report 2022-08-15 · accession 0001493152-22-023387 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-08-17 | 2022-08-15 | IMDX | Paulsen Gisela | Pres, COO | A - Grant | $0.00 | +525.0K | 191.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, no par value | 2022-08-15 | A | A | 350,000 | $0.00 | 541,500 | D | — | — | (F2) The Restricted Stock Units shall vest on January 1, 2024 based on the achievement of a pre-determined financial objective related to the Issuer's available cash. |
| 2 | Common | Common Stock, no par value | 2022-08-15 | A | A | 175,000 | $0.00 | 191,500 | D | — | — | (F1) The Restricted Stock Units shall vest one year from the date of grant, subject to the Reporting Person's continued service from the date of grant until the vesting date. |